Robbins Andrew R

Robbins Andrew R is listed in filings as President and CEO at Cogent Biosciences, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including 6 public disclosures. Recent filings connect the profile to Cogent Biosciences, Inc. (COGT). The current snapshot covers public activity from Jan 27, 2025 to May 21, 2026. Reported amounts are shown as $14.5M to $8.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.